Company research
LataMed AI Corp.
CIK 1477960Updated Sep 24, 2026
LMED price & chart
Loading TradingView…
OTC:LMED on TradingView ↗About the company
We are a recently re-organized development stage company but have not yet commenced operations in our business. We expect to incur operating losses in the foreseeable future.
In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Other Events
Items 8.01
Regulation FD Disclosure
Items 7.01, 9.01
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 5.03, 9.01
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 0Source | 0Source | 0Source |
| Current assets: | |||
| Assets, CurrentUSD | 0Source | 0Source | 0Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 630,860Source | 573,575Source | 500,363Source |
| Stockholders’ equity: | |||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 44,298Source | 29,278Source | 257Source |
| Additional Paid in CapitalUSD | 28,925,628Source | 28,790,448Source | 25,631,643Source |
| Retained Earnings (Accumulated Deficit)USD | -29,600,786Source | -29,393,301Source | -26,132,263Source |
| Stockholders' Equity Attributable to ParentUSD | -630,860Source | -573,575Source | -500,363Source |
| Liabilities and EquityUSD | 0Source | 0Source | 0Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 630,860Source | 573,575Source | 500,363Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | -3,261,038Source | -1,733,722Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -205,791Source | -66,834Source | -70,301Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 205,791Source | 66,834Source | 70,301Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 0Source | 0Source | 0Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 0Source | 0Source | 0Source |
| Income Taxes Paid, NetUSD | 0Source | 0Source | 0Source |
| Additional Financial Items | |||
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | 0Source | — | -875,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 73,582Source | 0Source |
| General and Administrative ExpenseUSD | 149,450Source | 3,213,828Source | 762,878Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -207,485Source | -3,261,038Source | -1,733,722Source |
| Operating ExpensesUSD | 171,852Source | 3,297,858Source | 828,927Source |
| Other Nonoperating Income (Expense)USD | -35,633Source | 36,820Source | -904,795Source |
| Proceeds from Issuance of Common StockUSD | 150,200Source | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 0Source | 0Source | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Operating Income (Loss)USD | -171,852Source | -3,297,858Source | -828,927Source |
| Other Nonoperating Income (Expense)USD | -35,633Source | 36,820Source | -904,795Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -207,485Source | -3,261,038Source | -1,733,722Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -207,485Source | -3,261,038Source | -1,733,722Source |
| Earnings Per Share, DilutedUSD per share | — | -0.11Source | -0.02Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | 29,276,895Source | 88,917,549Source |
| Additional Financial Items | |||
| General and Administrative ExpenseUSD | 149,450Source | 3,213,828Source | 762,878Source |
| Interest ExpenseUSD | 35,633Source | 36,762Source | 29,795Source |
| Interest Expense, DebtUSD | 7,182Source | 12,975Source | 14,682Source |
| Operating ExpensesUSD | 171,852Source | 3,297,858Source | 828,927Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 0Source | 0Source | 0Source |
Offerings
Registration 333-284181
- Ticker
- CBBB
Filing attachments
lmed_ex991.htm · 8-K · 2026-07-15
EX-99.1 2 lmed_ex991.htm PRESS RELEASE cctc_ex991.htm EXHIBIT 99.1 LataMed AI Corp. Announces Effectiveness of 5-for-1 Forward Stock Split Caracas, Venezuela - July 15, 2026 - LataMed AI Corp. (OTC: LMED) (the “Company”) today announced that its previously announced 5-for-1 forward stock split has become effective at the opening of trading following publication of the corporate action on the FINRA Daily List dated July 14, 2026. In connection with the forward stock split, the Company's c…
Read attachment ↗cbbb_ex107.htm · S-1 · 2025-01-08
EX-FILING FEES 5 cbbb_ex107.htm FILING FEE cbbb_ex107.htm EXHIBIT 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) CATALYST CREW TECHNOLOGIES CORP. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Fee Calculation Amount Registered(2) Proposed Maximum Maximum…
Read attachment ↗